Jubilant Pharmova is currently trading at Rs. 698.20, up by 1.30 points or 0.19% from its previous closing of Rs. 696.90 on the BSE.
The scrip opened at Rs. 719.85 and has touched a high and low of Rs. 719.85 and Rs. 694.65 respectively. So far 21774 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 981.90 on 08-Feb-2021 and a 52 week low of Rs. 591.98 on 10-Nov-2020.
Last one week high and low of the scrip stood at Rs. 725.45 and Rs. 692.15 respectively. The current market cap of the company is Rs. 11150.48 crore.
The promoters holding in the company stood at 50.68%, while Institutions and Non-Institutions held 26.57% and 22.75% respectively.
Jubilant Pharmova has reported results for first quarter ended June 30, 2021.
The company has reported net loss at Rs 1.13 crore for the quarter under review as compared to net profit at Rs 52.04 crore for the same quarter in the previous year. Total income of the company decreased by 96.81% at Rs 24.37 crore for Q1FY22 as compared Rs 762.93 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a rise of 82.43% in its net profit attributed to the owners at Rs 160.56 crore for the quarter under review as compared to net profit of 88.01 crore for the same quarter in the previous year. Total income of the company increased by 41.26% at Rs 1638.54 crore for Q1FY22 as compared Rs 1159.98 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1521.95 |
Dr. Reddys Lab | 6279.95 |
Cipla | 1407.55 |
Zydus Lifesciences | 963.50 |
Lupin | 1640.30 |
View more.. |